Diabetic Retinopathy News and Research

RSS
In the initial stages, people with diabetic retinopathy may not notice their vision changing. Diabetics sometimes experience rapid changes in blood sugar that can temporarily cause blurry vision even when retinopathy is not present. If a person notices a few specks or spots floating in his visual field, this may mean he has developed proliferative diabetic retinopathy, the growth of abnormal new blood vessels on the retina and optic nerve. High blood sugar levels have been linked in studies to retinal blood vessel abnormalities. Blurred vision may occur when the macula--the small area at the center of the retina--swells as it fills with fluid that has leaked from retinal blood vessels. Because damage to the eye often develops slowly, early detection of diabetes and control of blood sugar through diet and medications can make a crucial difference in saving vision.

Effective diabetic retinopathy treatments include laser photocoagulation for early to moderate stages and a microsurgery called vitrectomy for repair of eyes with extensive damage. Injectable and oral medications that act on abnormal blood vessels to control diabetic retinopathy before vision loss occurs are now in development. Early detection would be key to the effectiveness of these treatments, also.
New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness

New small-molecule drugs show potential clinical utility in treating world’s leading causes of blindness

Diabetes WA calls for greater recognition of diabetes impact on Aboriginal Communities

Diabetes WA calls for greater recognition of diabetes impact on Aboriginal Communities

The role of caffeine in preventing diabetic retinopathy

The role of caffeine in preventing diabetic retinopathy

UVA research provides new insight into common causes of vision loss

UVA research provides new insight into common causes of vision loss

Study investigates anti-VEGF treatment for inflammatory eye disease in HTLV-1–infected ocular cells

Study investigates anti-VEGF treatment for inflammatory eye disease in HTLV-1–infected ocular cells

Early treatment of diabetes-related eye disease does not improve visual acuity

Early treatment of diabetes-related eye disease does not improve visual acuity

Study reveals why hypoglycemic episodes worsen diabetic retinopathy

Study reveals why hypoglycemic episodes worsen diabetic retinopathy

Study directly links gut leakage with retinopathy severity in people with Type 1 diabetes

Study directly links gut leakage with retinopathy severity in people with Type 1 diabetes

Endogenous system may be responsible for delayed onset of diabetic retinopathy

Endogenous system may be responsible for delayed onset of diabetic retinopathy

High-quality reference genome assembly of the Nile rat facilitates diabetes research

High-quality reference genome assembly of the Nile rat facilitates diabetes research

NEI researchers create a high-resolution map of retinal cell chromatin contract points

NEI researchers create a high-resolution map of retinal cell chromatin contract points

Researchers uncover a key process involved in diabetes-related vision loss

Researchers uncover a key process involved in diabetes-related vision loss

New imaging approach could help accelerate the development of new treatments for eye diseases

New imaging approach could help accelerate the development of new treatments for eye diseases

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Crying out for new disease diagnoses

Crying out for new disease diagnoses

Discovery could lead to a simple screening process for predicting heart attack risk

Discovery could lead to a simple screening process for predicting heart attack risk

Topical ocular administration of progesterone could be viable treatment for retinitis pigmentosa

Topical ocular administration of progesterone could be viable treatment for retinitis pigmentosa

Unusual partners are key to making more blood vessels

Unusual partners are key to making more blood vessels

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

New study offers valuable information on ocular drug metabolism and pharmacokinetics

New study offers valuable information on ocular drug metabolism and pharmacokinetics

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.